Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial-Reference-Cited by-同舟云学术

Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial

Published:2021-04-01 Issue:4 Volume:178 Page:352-362
ISSN:0002-953X
Container-title:American Journal of Psychiatry
language:en
Short-container-title:AJP

Author:

Dwyer Jennifer B.¹,Landeros-Weisenberger Angeli¹,Johnson Jessica A.¹,Londono Tobon Amalia¹,Flores José M.¹,Nasir Madeeha¹,Couloures Kevin¹,Sanacora Gerard¹,Bloch Michael H.¹

Affiliation:

1. Yale Child Study Center (Dwyer, Landeros-Weisenberger, Johnson, Londono Tobon, Flores, Nasir, Bloch), Department of Radiology and Biomedical Imaging (Dwyer), and Department of Psychiatry (Londono Tobon, Flores, Sanacora, Bloch), Yale School of Medicine, New Haven, Conn.; Department of Pediatrics, Stanford University, Stanford, Calif. (Couloures).

Publisher

American Psychiatric Association Publishing

Subject

Psychiatry and Mental health

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel rapid treatment options for adolescent depression;Pharmacological Research;2024-03

2. Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta, Canada;Frontiers in Psychiatry;2024-01-08

3. Exploring Predictors of Ketamine Response in Adolescent Treatment-Resistant Depression;Journal of Child and Adolescent Psychopharmacology;2024-01-03

4. Psychoanalytically informed care and behavioral medicine: Consideration and recommendations for evidence-based practice in institutions.;Psychoanalytic Psychology;2024-01

5. The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder;Trials;2023-10-24